Oxford Immunotec Global PLC·4

Mar 19, 5:12 PM ET

Keiley Elizabeth M 4

4 · Oxford Immunotec Global PLC · Filed Mar 19, 2018

Insider Transaction Report

Form 4
Period: 2018-03-15
Keiley Elizabeth M
VP & General Counsel
Transactions
  • Award

    Ordinary Shares

    2018-03-15+10,88235,133 total
  • Award

    Share Option (Right to Buy)

    2018-03-15+47,58747,587 total
    Exercise: $13.24Exp: 2028-03-15Ordinary Shares (47,587 underlying)
Footnotes (2)
  • [F1]Options granted under Issuer's 2013 Share Incentive Plan.
  • [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4